Canopy Growth Corp current report, 18 March 2021

Business Context and Reporting Period

Canopy Growth Corporation filed this Form 8-K on March 18, 2021, reporting entry into a new senior secured credit facility and related Regulation FD disclosure. The filing is a transaction update and does not provide operating results for a reporting period.

Financing and Key Financial Metrics

  • Facility: Five-year senior secured term loan with aggregate principal of US$750 million.
  • Net proceeds: Approximately US$710 million after estimated fees, expenses, and transaction costs.
  • Use of proceeds: Working capital and general corporate purposes, including growth investments, acquisitions, capital expenditures, and strategic initiatives.
  • Maturity: March 18, 2026, with no scheduled amortization payments.
  • Interest: At the borrower’s option, initially LIBOR subject to a 1.00% floor plus an 8.50% margin, or an alternate base rate subject to a 2.00% floor plus a 7.50% margin. Margins may increase upon specified delisting events or failure to obtain credit ratings within 180 days of closing.
  • Guarantees and collateral: Material Canadian and U.S. restricted subsidiaries guarantee the facility. The facility is secured by substantially all assets, including material real property, of the borrowers and guarantors.
  • Liquidity covenant: Minimum liquidity of US$200 million at the end of each fiscal quarter.

Material Changes Versus the Prior Comparable Period

The filing does not present comparative financial statements or operating metrics. The material change disclosed is the addition of the US$750 million secured term loan facility and the associated increase in secured borrowing obligations.

Outlook, Covenants, Risks, and Unusual Items

  • Voluntary prepayments before March 18, 2023 generally require a make-whole premium. Prepayments between March 18, 2023 and March 18, 2025 carry premiums of 5.00% or 2.50%, depending on timing; prepayments on or after March 18, 2025 have no premium.
  • Mandatory prepayments may be required from proceeds of certain non-ordinary-course asset sales, casualty or condemnation events, and otherwise prohibited indebtedness, subject to specified reinvestment rights.
  • The Credit Agreement includes restrictions on indebtedness, liens, investments, acquisitions, asset sales, restricted payments, affiliate transactions, mergers, business changes, and other corporate actions.
  • Events of default include payment or covenant breaches, cross-defaults, changes in control, insolvency, material judgments, certain pension liabilities, impairment of loan documentation, repeal of specified cannabis legislation, defaults under material cannabis authorizations, loss of certain Health Canada licenses, and certain delisting events.
  • The significant financing costs, high stated interest margins, collateral package, and minimum-liquidity covenant may increase financial and refinancing risk. The filing does not provide management guidance or an operating forecast.

Important Facts for Investors to Verify

  • Review the complete Credit Agreement filed as Exhibit 10.1, including redacted provisions and detailed definitions of liquidity, covenants, defaults, and permitted transactions.
  • Verify the final net cash proceeds and the facility’s effect on Canopy Growth’s total debt, cash balance, interest expense, and liquidity in subsequent financial filings.
  • Assess compliance with the US$200 million minimum-liquidity covenant and other affirmative and negative covenants.
  • Monitor credit-rating requirements, potential margin step-ups, prepayment premiums, and the March 18, 2026 maturity.
  • Evaluate the scope of subsidiary guarantees and pledged assets, as well as risks related to cannabis legislation, regulatory authorizations, Health Canada licenses, and potential delisting events.